ORKA — Oruka Therapeutics Inc. price, chart and key statistics

Price data

Price

$71.93

YTD price return

+137.31%

YTD total return

+137.31%

Next earnings

Nov 11, 2026

Market cap

4.8B2016-12 310.6M2026-10 4.8B+1434.3% over the window

Enterprise value

3.9B

Shares outstanding

66.2M2016-06 503.7K2026-06 66.2M+13045.0% over the window

52W low

$25.11

52W high

$115.52

From 52W high

-37.73%

From 52W low

+186.46%

52W range

52%

Volume

Rel volume

1.42×

30D volume

976.7K

30D $ vol

84.1M

Fundamentals

EPS (ttm)

-$2.012021-06 -$1.112025-06 -$2.37+113.2% over the window

FCF (ttm)

-101.2M2016-06 -12.4M2026-06 -101.2M+713.3% over the window

FCF/share

-$1.532016-06 -$24.692026-06 -$1.53-93.8% over the window

Book value/share

$16.832016-06 $61.332026-06 $16.83-72.6% over the window

ROE

-11.92%2016-06 -43.8%2026-06 -11.9%-72.8% over the window

ROA

-11.66%2016-06 -41.4%2026-06 -11.7%-71.9% over the window

Current ratio

38.512016-06 15.752026-06 38.51+144.5% over the window

Growth (CAGR, ttm) · 10Y

Shares

+76.86%2025-06-30 → 2026-06-3037.5M → 66.2M (+76.8% total)+59.88%2023-03-31 → 2026-06-3014.4M → 66.2M (+359.5% total)+35.67%2021-06-30 → 2026-06-3014.4M → 66.2M (+359.5% total)+62.89%2016-06-30 → 2026-06-30503.7K → 66.2M (+13045.0% total)

Per-share growth (CAGR, ttm) · 10Y

Book value/share

+83.53%2025-06-30 → 2026-06-30$9.18 → $16.83 (+83.5% total)+73.42%2023-03-31 → 2026-06-30$2.81 → $16.83 (+498.5% total)+31.71%2021-06-30 → 2026-06-30$4.25 → $16.83 (+296.3% total)-12.13%2016-06-30 → 2026-06-30$61.33 → $16.83 (-72.6% total)

Price

+171.01%2025-10-16 → 2026-10-16$26.56 → $71.93 (+170.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+43.69%2023-10-16 → 2026-10-16$24.24 → $71.93 (+196.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+16.52%2021-10-15 → 2026-10-16$33.48 → $71.93 (+114.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-18.15%2016-10-14 → 2026-10-16$533.52 → $71.93 (-86.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

+171.01%2025-10-16 → 2026-10-16$26.56 → $71.93 (+170.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+43.69%2023-10-16 → 2026-10-16$24.24 → $71.93 (+196.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+16.52%2021-10-15 → 2026-10-16$33.48 → $71.93 (+114.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-18.15%2016-10-14 → 2026-10-16$533.52 → $71.93 (-86.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-35.8×2016-12 -20.212026-10 -35.86+77.4% over the window

Fwd P/E

-28.7×

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

4.3×2016-12 11.732026-10 4.28-63.5% over the window

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-2.12%2016-09 -4.4%2026-06 -1.6%-63.8% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 66.2M ÷ 37.5M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-76.86%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-76.86%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($419.8M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-76.86%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-6.6M) ÷ today's market cap ($4.8B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

-0.14%2016-09 0.0%2026-06 -0.1%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-6.6M + TTM dividends $0) ÷ today's market cap ($4.8B). Same caveat as the cash buyback yield.

-0.14%2016-09 0.0%2026-06 -0.1%

Vs own 10Y history

P/B

15th